Merck Opens Bioprocessing Center in South Korea
Merck's largest life sciences investment to date in the Asia-Pacific region expands regional manufacturing capacity.
life science business
Acquisitions for Brenntag in Australia and USA
Leading international distributor Brenntag has acquired the life science business of Ravenswood, strengthening its position in the Australian and New Zealand specialties market. The deal is expected to close next month.
Merck Germany Doubles HPAPI Potential
The Life Science business segment of German pharmaceuticals, chemicals and life sciences group Merck has widened its US plant for high-potent active pharmaceutical ingredients (HPAPIs) at Verona, near Madison, Wisconsin to 6,500 m2.
